BeiGene, Ltd.(688235) Stock Price Today

CN Stock MarketDetailed Quotes

688235 BeiGene, Ltd.

Watchlist

250.78
+2.58+1.04%

Market Closed Apr 3 15:00 CST

351.18BMarket Cap-53.83P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

JMP Securities Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $348
Moomoo NewsApr 4 06:31 ET · Ratings
BeiGene's Strategic Positioning and Growth Potential: A Buy Recommendation by Reni Benjamin
TipRanksApr 4 00:35 ET · Ratings
BeiGene Halts Ociperlimab Amid Poor Phase III Trial Predictions
Yahoo FinanceApr 3 12:37 ET
BeiGene Has Discontinued Its Clinical Development Program For Ociperlimab (BGB-a1217), An Anti-TIGIT Antibody, As A Potential Treatment For Lung Cancer
BenzingaApr 3 06:03 ET
Express News | Beigene Ltd - Study Unlikely to Meet Primary Endpoint of Overall Survival
ReutersApr 3 06:01 ET
Express News | Beigene Ltd - Independent Data Monitoring Committee Recommends Termination of Phase 3 Advantig-302 Trial
ReutersApr 3 06:00 ET

Comments

EvaHuang

Nov 12, 2024 20:46

Seems the stock is forgotten by the market

$BEIGENE (06160.HK)$

Gator on Wall Street

Feb 7, 2024 17:18

CIMB: Healthcare Overall – Overweight

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
alphaedgeinvest...
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

Gator on Wall Street

Jan 24, 2024 10:22

China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70 - Alpha Edge Investing
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

Spinee

Jan 17, 2024 16:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

Gator on Wall Street

Aug 30, 2022 17:23

DBS: China Healthcare Sector – Pharmaceutical Packaging

https://alphaedgeinvesting.com/2022/08/30/dbs-china-healthcare-sector-pharmaceutical-packaging/
$MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $CSPC PHARMA (01093.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

688235 BeiGene, Ltd.

Trade Overview

Capital Trend

News

Comments

Market Insights

Market Headlines

Latest News

Investment Course